Products and Services
-
EDC: Control Your Data, Control Your Study
2/16/2023
Streamline data, maximize efficiencies, tighten up costs, and reach end goals faster using Medrio’s powerful and intuitive EDC tool.
-
GMO Solutions
6/27/2023
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).
-
Pharmacometric Services
6/27/2023
Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.
-
TrialKit: Your Comprehensive Solution For Non-Interventional Studies
4/5/2024
Elevate Your Clinical Research Data Collection
-
Clinical And Regulatory Strategy
11/7/2023
Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.
-
Get Expert Regulatory Consultancy For Your Clinical Trials
12/20/2022
Novotech’s Medical and Regulatory Consulting team offers full range of pre-clinical, regulatory affairs support, medical and pharmacovigilance consulting services.
-
Cell & Gene Therapy Solutions
9/29/2023
Your therapy can make all the difference. Together, we’ll unlock its potential.
-
Identify, Substantiate, And Communicate Compelling Propositions
12/6/2023
Shape crucial market choices and value substantiation with the depth and breadth of integrated clinical EHRs, claims, and patient reported outcome data, backed by analytical and therapy area expertise.
-
End-To-End Ophthalmic Drug Development Solutions
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Pharmacovigilance Solutions
3/20/2024
Free your safety and clinical teams to focus on what matters most.